TY  - GEN
AU  - García-Vega,Yanelda
AU  - García-García,Idrian
AU  - Collazo-Caballero,Sonia E
AU  - Santely-Pravia,Egla E
AU  - Cruz-Ramírez,Alieski
AU  - Tuero-Iglesias,Angela D
AU  - Alfonso-Alvarado,Cristian
AU  - Cabrera-Placeres,Mileidys
AU  - Castro-Basart,Nailet
AU  - Duncan-Roberts,Yaquelín
AU  - Carballo-Treto,Tania I
AU  - Soto-Matos,Josanne
AU  - Izquierdo-Toledo,Yoandy
AU  - Vázquez-Blomquist,Dania
AU  - García-Iglesias,Elizeth
AU  - Bello-Rivero,Iraldo
TI  - Pharmacokinetic and pharmacodynamic characterization of a new formulation containing synergistic proportions of interferons alpha-2b and gamma (HeberPAG) in patients with mycosis fungoides: an open-label trial
SN  - 2050-6511
PY  - 2016///0623
KW  - Adult
KW  - Aged
KW  - Antineoplastic Agents
KW  - adverse effects
KW  - Biomarkers
KW  - blood
KW  - Chemistry, Pharmaceutical
KW  - Cuba
KW  - Drug Combinations
KW  - Drug Stability
KW  - Drug Synergism
KW  - Female
KW  - Half-Life
KW  - Humans
KW  - Injections, Intramuscular
KW  - Interferon alpha-2
KW  - Interferon-alpha
KW  - Interferon-gamma
KW  - Male
KW  - Middle Aged
KW  - Mycosis Fungoides
KW  - Neopterin
KW  - agonists
KW  - Recombinant Proteins
KW  - Skin Neoplasms
N1  - Publication Type: Clinical Trial; Journal Article
UR  - https://doi.org/10.1186/2050-6511-13-20
ER  -